Navigation Links
Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
Date:10/23/2007

-- Further analysis of phase 2 breast cancer data show preferential activity of adecatumumab on inhibiting the formation of new metastases -- Results from 169 patients treated with adecatumumab demonstrate an

apparent lack of immunogenicity of the antibody

BETHESDA, Md., Oct. 23 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for the treatment of cancer, inflammation and autoimmune diseases, today announced that new data from two previously reported phase 2 studies were presented at the joint international meeting of the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and European Organization for Research and Treatment of Cancer (EORTC) being held in San Francisco, CA, from October 22-26.

Abstract A71 reports on a further analysis of data from the phase 2 trial investigating adecatumumab as single agent in metastatic breast cancer (MBC). Previously, longer time to tumor progression (TTP) has been shown for patients receiving higher doses of adecatumumab and expressing high levels of EpCAM (HR = 0.433 for the comparison of high dose/high EpCAM versus low dose/low EpCAM; p=0.0057). All data have now been re-evaluated in order to investigate the reasons for progression. Whereas no obvious differences were detected for the progression of pre-existing target lesions, a significantly lower incidence of new metastases was observed in patients with very high EpCAM expression (only 3 out of 18 patients with new lesions at week 6; 16.7%) as compared to those with low EpCAM (14 out of 29 patients; 48.3%; p= 0.034). A dose-dependency of this effect was
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Wisconsin Assembly passes capital investment bill, revised CAPCO program not presented
2. Olympics of biotechnology has international flavor
3. Traffic data firm navigates international business
4. Catalyst International profit exceeds expectations
5. Lack of broadband hamstrings international videoconferencing
6. 30 days to success: Three simple steps to create your own international startup
7. TEKLYNX International announces new RFID software
8. Ruling enforces international trademark electronic filing requirements
9. Eleftheriou to lead Catalyst International
10. Internet trademark war goes international
11. International eyes drawn to Madisons games research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Program Connects Customers with Partn...cted with DNA Genotek Products , ...NA Genotek , a leading provider of products for bi...aration, today announced its new global partner pr... for DNA Genotek,s partner community and is design...
(Date:11/23/2009)...Ill. You can think of it as origami very high-te...linois have developed a technique for fabricating ...ctures from thin films by coupling photolithograph...nteractions. , The films, only a few microns thic...le with thicker pieces of the same material. , "T...
(Date:11/23/2009)...SSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioScienc...developmentcompanythatidentifiesandadvancesadivers...usstagesofdevelopment,todayreportedthatCytopia(ASX...tingCYT387,apotent,orally-administeredJAK1/JAK2inh...ster,Minnesota.AproposaltomergeCytopiaintoYMhasbee...
(Date:11/23/2009)...BY,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc...h.DasitsPresidentandCEO. ,, Abramsbringsmoretha...nimex.Heisaco-inventorofthenuclearmedicineimaginga...tthey,plcwherehewasManager,BiomedicalResearchWorld...ngley,BCandwasPresidentandCEOfrom1996to2006.AnorME...
Breaking Biology Technology:DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2
...f Operations Outside the US In ...Nov. 6 Northwest,Biotherapeutics, Inc. (OTC Bulle...ced that it has obtained US$1.65 million in fundin... (the "Notes") with SDS Capital Group SPC,Ltd ("SD... Investors"). A,significant portion of the proceed...
...ing Process Documentation for Customer ...., Nov. 5 BioLife Solutions Inc.,(OTC Bulletin Bo...oprietary,hypothermic storage and cryopreservation...ay announced that it has submitted a Master File t...FDA) for the Company,s,HypoThermosol preservation ...
...Technologies, Inc.,a provider of innovative microd...e research, today announced that it has shipped it...application to The Genome Center (GC) at,the Washi...a world leader,in genomics research., Under RainD...l provide,its new RDT 1000 and expert training to ...
Other Biology Technology:Northwest Secures US$1.65 Million Debt Financing 2Northwest Secures US$1.65 Million Debt Financing 3Northwest Secures US$1.65 Million Debt Financing 4BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 2BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues 3RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis 2
(Date:11/23/2009)...evidence that the "synergistic" effect of early-li...ion and indoor endotoxin causes more harm to devel... , Environmental health scientists at the Unive...shown that children exposed to both high levels of...ring early life are six times more likely to exper...
(Date:11/23/2009)...ion Society says that western lowland gorillas liv...of the "mother lode" of more than 125,000 gorillas...eatened by growing humans activity in the region. ...orests adjacent to the southwest border of Lac Tl ...hat high densities of the great apes still exist i...
(Date:11/23/2009)...vailable for the H1N1 virus has been sent to vacci...cination marks the first time vaccine has been sen..., Iowa State University,s Hank Harris, professor...mer and has been shipping preventive doses to swin...al weeks., The latest vaccines were shipped to a...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2MitraClip 28R 29 Therapy Introduced in Austria 4958 1MitraClip 28R 29 Therapy Introduced in Austria 4958 2MitraClip 28R 29 Therapy Introduced in Austria 4958 3Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 56624 1Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 56624 2Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 56624 3Mayo Clinic Center for Innovation Collaborative Symposium on Innovations in Health Care Experience 56624 4Peter G Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and High 56622 1Peter G Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and High 56622 2Peter G Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and High 56622 3Peter G Peterson Foundation Releases The Lewin Group Study Showing Current House Health Care Reform Proposal Would Lead to Expanded Coverage and High 56622 4
...ia, PA September 4, 2008) The tumor suppressor ge...gnostic biomarker in cases of soft tissue sarcoma ... of researchers, including scientists at the Sbarr...cine at the College of Science and Technology at T...nt of Human Pathology and Oncology, University of ...
...l. (Sept. 3, 2008) Scientists at the U.S. Departm...have won an $800,000 EUREKA award from the Nationa...precise molecular ruler for measuring distances wi...Multi-wavelength Anomalous Diffraction using Mediu...dramatically reduce the time necessary to reveal t...
... Conn. Yale molecular and evolutionary biologists ...sts produced the full genome sequence of Trichopl...organisms, providing a new insight into the evolut...d in the online edition of the journal Nature sh... nuclear genomes found in a multi-cellular creatur...
Other Biology News:International team reveals first prognosticator of survival in aggressive cancer 2NIH awards Argonne $800,000 to develop tool to measure distances within proteins 2Trichoplax genome sequenced -- 'rosetta stone' for understanding evolution 2
Rat Anti-Mouse OSMR Monoclonal Antibody, Unconjugated, Clone 30-1 from MBL International
Mouse Anti-ROCK-1 (cleaved) Monoclonal Antibody, Unconjugated from BioVision
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Biology Products: